Skip to main content
. Author manuscript; available in PMC: 2016 May 18.
Published in final edited form as: Mucosal Immunol. 2015 Oct 14;9(3):757–766. doi: 10.1038/mi.2015.99

Table 2.

Comparison of SPM impact on the resolution interval (Ri) in mouse peritonitis*

Agonist Dose Shortening of Ri (%) Reduction of ψmax (%)
RvD1 50 ng/mouse19 40 40
RvD2 50 ng/mouse 74 41
RvD3 50 ng/mouse40 92 47
MaR1 50 ng/mouse 76 58
*

The impact of SPM administered i.p. at initiation of inflammation) on resolution interval in murine self-limited peritonitis initiated by i.p. injection of 1mg zymosan i.p. or E. coli, (105 colony forming units, c.f.u). For direct comparison see 19, 40.